This is an aggregated industry headline. Read the full story at FiercePharma →
FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483
The agency spotted seven observations at Dr. Reddy's Bachupally, Hyderabad, biologics plant following a mid-June inspection.
By FiercePharma
· Jun 27, 2026
· via FiercePharma
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFierceBiotech ↗
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial tea…
The WeekBriefing
The European Commission has launched formal antitrust proceedings into Sanofi’s flu vaccine marketing. The cas…
The WeekSTAT News ↗
What were the vibes like at BIO 2026? STAT reporters take you inside the annual industry conference on the lat…